Primary giant cell malignant fibrous histiocytoma of the lung: a rare case report and literature review
Authors:
Open Access
- 1 November 2020
- journal article
- review article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 9 (11) , 7350-7358
Abstract
Malignant fibrous histiocytoma (MFH) usually involves the extremities. Among MFH, primary giant cell malignant fibrous histiocytoma of the lung is extremely rare, with nonspecific symptoms. A 45-year-old woman was first diagnosed as sclerosing hemangioma due to long-term persistent cough and blood in sputum. One year later, the condition became worse and hemoptysis occurred. At the second visit, the same mass was found to be larger than the previous one. Lobectomy was performed and the primary giant cell MFH of the lung was confirmed. Renal and sacrum metastasis occurred six months after operation. The efficacy of hypofractionation radiotherapy and immuno targeted follow-up therapy is significant. At present, there is no standard treatment plan. For the patients in the early stage, surgical resection is the main treatment method; but for the patients in the middle and late stage, the treatment is relatively single. So early diagnosis and treatment are particularly important, In this paper, we first report the use of pembrolizumab combined with anlotinib in a patient with advanced giant cell MFH of the lung, with failure of routine treatment. The development of the disease had successfully delayed and satisfactory results were observed. Therefore, it is very necessary to emphasize the choice of treatment plan to improve the prognosis of patients.Keywords
This publication has 18 references indexed in Scilit:
- Primary Pulmonary Malignant Fibrous HistiocytomaCase Reports in Pulmonology, 2015
- Multimodality Management of Metastatic Patients With Soft Tissue Sarcomas May Prolong SurvivalAmerican Journal of Clinical Oncology, 2014
- WHO classification of soft tissue tumours: an update based on the 2013 (4th) editionPathology, 2014
- Combined pulmonary lobectomy for surgical treatment of a malignant fibrous histiocytoma of the chest wall: a case reportDiagnostic Pathology, 2014
- Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytomaScientific Reports, 2013
- Endobronchial Malignant Fibrous Histiocytoma: Case Report of an Unusual Presentation and Palliative Flexible Bronchoscopic ResectionRespiratory Care, 2013
- Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931European Journal of Cancer, 2013
- Successful Treatment of Malignant Fibrous Histiocytoma Originating in the Chest Wall: Report of a CaseSurgery Today, 2006
- Primary giant cell malignant fibrous histiocytoma of the lung: A case reportPathology International, 1999
- Malignant Fibrous Histiocytoma of the Lung: Prognosis and Therapy of a Rare DiseaseThe Thoracic and Cardiovascular Surgeon, 1987